LLY vs RVTY
By Alex · Tickerpine
Eli Lilly and Company vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | RVTY |
|---|---|---|
| Price | $1,273.46 | $158.77 |
| Market cap | $1.14T | $17.72B |
| P/E ratio | 42.7 | 76.0 |
| ROE | 102.29% | 3.21% |
| Profit margin | 33.53% | 8.16% |
| Revenue growth | 47.70% | 1.30% |
| Dividend yield | 0.54% | 0.18% |
| Beta | 0.45 | 1.06 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs RVTY in plain English
- LLY is the bigger company — about 64.1× the market cap of RVTY.
- LLY is cheaper on earnings (P/E 42.7 vs 76.0).
- LLY earns a higher return on equity (102% vs 3%).
- LLY is growing revenue faster (48% vs 1%).
- LLY has the higher dividend yield (0.54% vs 0.18%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.